An open label pH comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
Study identifier:D9612L00082
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An Open-Label, 2-way Crossover Study of Steady-state Intragastric pH Control Comparing 2 Dosage Regimens of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
Medical condition
Barrett's esophagus
Phase
Phase 4
Healthy volunteers
No
Study drug
Esomeprazole, Lansoprazole
Sex
All
Actual Enrollment
80
Study type
Interventional
Age
18 Years - 70 Years
Date
Study Start Date: 01 Jan 2006
Primary Completion Date: -
Study Completion Date: 01 Apr 2007
Study design
Allocation: Randomized
Endpoint Classification: Pharmacodynamics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Debra Silberg
AstraZeneca
